{
  "ir_kind": "core",
  "metadata": {
    "source": {
      "id": "s41586-018-0024-3.pdf",
      "type": "paper"
    },
    "title": "Drug screening assay"
  },
  "protocol": {
    "detail_level": 0,
    "edges": [
      {
        "from": "s1",
        "to": "s1"
      }
    ],
    "start_step_id": "s1",
    "steps": [
      {
        "annotations": {
          "description": "Drug dilutions were performed in two series: 1) stepwise 2‑fold dilutions from 20 µM to 19.5 nM; and 2) stepwise 2‑fold dilutions from 15 µM to 29.3 nM."
        },
        "id": "s1",
        "inputs": [],
        "op": "annotate",
        "outputs": [],
        "params": {}
      }
    ]
  },
  "resources": {
    "containers": [],
    "data": [],
    "equipment": [],
    "materials": [
      {
        "id": "nutlin-3a",
        "type": "chemical"
      },
      {
        "id": "afatinib",
        "type": "chemical"
      },
      {
        "id": "MEK1/2 inhibitor III",
        "type": "chemical"
      },
      {
        "id": "AKT inhibitor VIII",
        "type": "chemical"
      },
      {
        "id": "5-FU",
        "type": "chemical"
      },
      {
        "id": "doxorubicin",
        "type": "chemical"
      },
      {
        "id": "SN-38",
        "type": "chemical"
      }
    ],
    "samples": []
  },
  "schema_version": "0.4"
}
